Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 5003

1.

Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry.

Amare AT, Schubert KO, Baune BT.

EPMA J. 2017 Sep 5;8(3):211-227. doi: 10.1007/s13167-017-0112-8. eCollection 2017 Sep. Review.

PMID:
29021832
2.

Efficacy of escitalopram monotherapy in the treatment of major depressive disorder: A pooled analysis of 4 Chinese clinical trials.

Li G, Shen Y, Luo J, Li H.

Medicine (Baltimore). 2017 Sep;96(39):e8142. doi: 10.1097/MD.0000000000008142.

3.

Treatment of Depression: A Systematic Review [Internet].

Swedish Council on Health Technology Assessment.

Stockholm: Swedish Council on Health Technology Assessment (SBU); 2004 Mar.

4.

Quality of Life, Functioning, and Depressive Symptom Severity in Older Adults With Major Depressive Disorder Treated With Citalopram in the STAR*D Study.

Steiner AJ, Recacho J, Vanle B, Dang J, Wright SM, Miller JS, Kauzor K, Reid M, Bashmi LE, Mirocha J, Danovitch I, IsHak WW.

J Clin Psychiatry. 2017 Jul;78(7):897-903. doi: 10.4088/JCP.16m11335.

PMID:
28858443
5.

Body Composition in Adolescents During Treatment With Selective Serotonin Reuptake Inhibitors.

Calarge CA, Mills JA, Janz KF, Burns TL, Coryell WH, Zemel BS.

Pediatrics. 2017 Jul;140(1). pii: e20163943. doi: 10.1542/peds.2016-3943. Epub 2017 Jun 16.

PMID:
28759400
6.

Vortioxetine for depression in adults.

Koesters M, Ostuzzi G, Guaiana G, Breilmann J, Barbui C.

Cochrane Database Syst Rev. 2017 Jul 5;7:CD011520. doi: 10.1002/14651858.CD011520.pub2. Review.

PMID:
28677828
7.

Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.

Brunoni AR, Moffa AH, Sampaio-Junior B, Borrione L, Moreno ML, Fernandes RA, Veronezi BP, Nogueira BS, Aparicio LVM, Razza LB, Chamorro R, Tort LC, Fraguas R, Lotufo PA, Gattaz WF, Fregni F, Benseñor IM; ELECT-TDCS Investigators.

N Engl J Med. 2017 Jun 29;376(26):2523-2533. doi: 10.1056/NEJMoa1612999.

PMID:
28657871
8.

Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates.

Yang A, Ciolino JD, Pinheiro E, Rasmussen-Torvik LJ, Sit DKY, Wisner KL.

J Clin Psychiatry. 2017 May;78(5):605-611. doi: 10.4088/JCP.16m11044.

PMID:
28570796
9.

Mindfulness, Quality of Life, and Severity of Depressive Symptoms Among Patients With Schizophrenia and Patients With Major Depressive Disorder.

Rayan AHR.

J Psychosoc Nurs Ment Health Serv. 2017 May 1;55(5):40-50. doi: 10.3928/02793695-20170420-05.

PMID:
28460148
10.

The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating?

Ribot R, Ouyang B, Kanner AM.

Epilepsy Behav. 2017 May;70(Pt A):5-9. doi: 10.1016/j.yebeh.2017.02.032. Epub 2017 Apr 10.

PMID:
28407526
11.

Effects of Patient Preferences on Outcomes in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) Study.

Dunlop BW, Kelley ME, Aponte-Rivera V, Mletzko-Crowe T, Kinkead B, Ritchie JC, Nemeroff CB, Craighead WE, Mayberg HS; PReDICT Team.

Am J Psychiatry. 2017 Jun 1;174(6):546-556. doi: 10.1176/appi.ajp.2016.16050517. Epub 2017 Mar 24.

PMID:
28335624
12.

Functional Connectivity of the Subcallosal Cingulate Cortex And Differential Outcomes to Treatment With Cognitive-Behavioral Therapy or Antidepressant Medication for Major Depressive Disorder.

Dunlop BW, Rajendra JK, Craighead WE, Kelley ME, McGrath CL, Choi KS, Kinkead B, Nemeroff CB, Mayberg HS.

Am J Psychiatry. 2017 Jun 1;174(6):533-545. doi: 10.1176/appi.ajp.2016.16050518. Epub 2017 Mar 24.

PMID:
28335622
13.

Pharmacotherapy of major depression in late life: what is the role of new agents?

Patel K, Abdool PS, Rajji TK, Mulsant BH.

Expert Opin Pharmacother. 2017 Apr;18(6):599-609. doi: 10.1080/14656566.2017.1308484. Epub 2017 Apr 4. Review.

PMID:
28317392
14.

Elucidation of the Role of Dorsal Raphe Serotonergic Neurons in Mood Regulation Using Pharmacological and Viral Vector-based Approaches.

Nagayasu K.

Yakugaku Zasshi. 2017;137(3):341-346. doi: 10.1248/yakushi.16-00240. Review. Japanese.

15.

A 35-year-old woman with low mood and concerns about her alcohol use.

Samokhvalov AV, Le Foll B.

CMAJ. 2017 Feb 27;189(8):E317-E318. doi: 10.1503/cmaj.160132. No abstract available.

PMID:
28246225
16.

Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach.

Chekroud AM, Gueorguieva R, Krumholz HM, Trivedi MH, Krystal JH, McCarthy G.

JAMA Psychiatry. 2017 Apr 1;74(4):370-378. doi: 10.1001/jamapsychiatry.2017.0025.

PMID:
28241180
17.

Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression.

Zhou C, Zhong J, Zou B, Fang L, Chen J, Deng X, Zhang L, Zhao X, Qu Z, Lei Y, Lei T.

PLoS One. 2017 Feb 27;12(2):e0172270. doi: 10.1371/journal.pone.0172270. eCollection 2017.

18.

Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCT.

Kato M, Takekita Y, Koshikawa Y, Sakai S, Bandou H, Nishida K, Sunada N, Onohara A, Hatashita Y, Serretti A, Kinoshita T.

J Psychiatr Res. 2017 Jun;89:97-104. doi: 10.1016/j.jpsychires.2017.02.003. Epub 2017 Feb 3.

PMID:
28213170
19.

Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis.

Jakobsen JC, Katakam KK, Schou A, Hellmuth SG, Stallknecht SE, Leth-Møller K, Iversen M, Banke MB, Petersen IJ, Klingenberg SL, Krogh J, Ebert SE, Timm A, Lindschou J, Gluud C.

BMC Psychiatry. 2017 Feb 8;17(1):58. doi: 10.1186/s12888-016-1173-2. Review. Erratum in: BMC Psychiatry. 2017 May 3;17 (1):162.

20.

A combination of probiotics and magnesium orotate attenuate depression in a small SSRI resistant cohort: an intestinal anti-inflammatory response is suggested.

Bambling M, Edwards SC, Hall S, Vitetta L.

Inflammopharmacology. 2017 Apr;25(2):271-274. doi: 10.1007/s10787-017-0311-x. Epub 2017 Feb 2.

PMID:
28155119

Supplemental Content

Loading ...
Support Center